Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Agios Pharmaceuticals Inc (AGIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH135515FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 enzyme used for the treatment of patients with R/R acute myeloid leukemia (AML); and TIBSOVO (ivosidenib), a prescription medicine used to treat adults with AML. Its pipeline products include AG-881, a pan-IDH mutant inhibitor intended for the treatment of hematologic malignancies and solid tumors; AG-270, an inhibitor of methionine adenosyltransferase 2a; and Mitapivat, a potent activator intended for the treatment of patients with pyruvate kinase deficiency. Agios is headquartered in Cambridge, Massachusetts, the US.

Agios Pharmaceuticals Inc Key Recent Developments

Mar 18,2021: Agios sponsors program promoting health literacy for patients with sickle cell disease
Feb 26,2021: Agios recognizes 14th annual Rare Disease Day and raises awareness of unmet needs in rare hemolytic anemias
Feb 25,2021: Agios reports fourth quarter and full year 2020 financial results
Feb 23,2021: Agios to Present at March Investor Conferences
Jan 11,2021: Agios to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021

This comprehensive SWOT profile of Agios Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Agios Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Agios Pharmaceuticals Inc – Key Information
Agios Pharmaceuticals Inc – Overview
Agios Pharmaceuticals Inc – Key Employees
Agios Pharmaceuticals Inc – Key Employee Biographies
Agios Pharmaceuticals Inc – Key Operational Heads
Agios Pharmaceuticals Inc – Major Products and Services
Agios Pharmaceuticals Inc – History
Agios Pharmaceuticals Inc – Company Statement
Agios Pharmaceuticals Inc – Locations And Subsidiaries
Agios Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Agios Pharmaceuticals Inc – Business Description
Agios Pharmaceuticals Inc – Corporate Strategy
Agios Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Agios Pharmaceuticals Inc – Strengths
Agios Pharmaceuticals Inc – Weaknesses
Agios Pharmaceuticals Inc – Opportunities
Agios Pharmaceuticals Inc – Threats
Agios Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Agios Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Agios Pharmaceuticals Inc, Key Information
Agios Pharmaceuticals Inc, Key Ratios
Agios Pharmaceuticals Inc, Share Data
Agios Pharmaceuticals Inc, Major Products and Services
Agios Pharmaceuticals Inc, History
Agios Pharmaceuticals Inc, Key Employees
Agios Pharmaceuticals Inc, Key Employee Biographies
Agios Pharmaceuticals Inc, Key Operational Heads
Agios Pharmaceuticals Inc, Other Locations
Agios Pharmaceuticals Inc, Subsidiaries
Agios Pharmaceuticals Inc, Key Competitors
Agios Pharmaceuticals Inc, SWOT Analysis
Agios Pharmaceuticals Inc, Ratios based on current share price
Agios Pharmaceuticals Inc, Annual Ratios
Agios Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Verastem Inc (VSTM):企業の財務・戦略的SWOT分析
    Summary Verastem Inc (Verastem) is a biopharmaceutical company which focus on the discovery, development and commercialization of novel small molecule drugs to treat cancer. The company’s marketed product COPIKTRA, an oral inhibitor of phosphoinositide 3-kinase (PI3K) is used to hematologic malignan …
  • Dufry AG (DUFN):企業の財務・戦略的SWOT分析
    Dufry AG (DUFN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • mBio Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary MBio Diagnostics Inc (MBio) is a medical device company that provides clinical diagnostics and sample testing solutions. The company offers MBio multiplex analyzer and disposable cartridges. Its MBio Array System is a fluorescence immunoassay system that provides measurement of analytes from …
  • Vertical Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Vertical Pharmaceuticals LLC (Vertical Pharmaceuticals), a subsidiary of Osmotica Pharmaceutical Corp, is a medicines marketing company that supplies niche prescription medicines. The company offers product category includes women's health and pain management. It provides products such as Co …
  • Canadian Zinc Corp.:企業の戦略・SWOT・財務情報
    Canadian Zinc Corp. - Strategy, SWOT and Corporate Finance Report Summary Canadian Zinc Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Capsugel Inc:企業の戦略的SWOT分析
    Capsugel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Mitsubishi Corporation (8058):電力:M&Aディール及び事業提携情報
    Summary Mitsubishi Corporation (Mitsubishi) is an integrated company that develops and operates businesses across industry including industrial finance, energy, metals, machinery, chemicals, living essentials, and environmental business. The company manufactures and markets a wide range of products, …
  • Penta-Ocean Construction Co Ltd
    Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Facebook Inc.:企業の戦略・SWOT・財務分析
    Facebook Inc. - Strategy, SWOT and Corporate Finance Report Summary Facebook Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bollore SA (BOL):企業の財務・戦略的SWOT分析
    Bollore SA (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • M.M.Warburg & Co Kgaa:企業の戦略・SWOT・財務分析
    M.M.Warburg & Co Kgaa - Strategy, SWOT and Corporate Finance Report Summary M.M.Warburg & Co Kgaa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Delticom AG:企業の戦略・SWOT・財務情報
    Delticom AG - Strategy, SWOT and Corporate Finance Report Summary Delticom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • JinkoSolar Holding Co Ltd (JKS)-エネルギー分野:企業M&A・提携分析
    Summary JinkoSolar Holding Co., Ltd. (JinkoSolar) is a manufacturer of solar products. The company manufactures and markets solar power products such as silicon ingots, silicon wafers, solar PV cells, and monocrystalline and multicrystalline photovoltaic (PV) panels. JinkoSolar distributes the solar …
  • SBS Transit Ltd.:企業の戦略・SWOT・財務情報
    SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report Summary SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sterlite Technologies Ltd (STRTECH):企業の財務・戦略的SWOT分析
    Summary Sterlite Technologies Ltd (Sterlite), a subsidiary of Vedanta Resources plc is a technology company that manufactures and markets power and telecom products and solutions. The company offers a wide range of data cables for structured cabling. Sterlite's application services include data cent …
  • GrowMax Resources Corp (BOE):企業の財務・戦略的SWOT分析
    Summary GrowMax Resources Corp (GrowMax), formerly Americas Petrogas Inc is an oil and gas company that offers exploration and development of conventional and unconventional oil and gas properties in Argentina. The company explores and develops phosphate and potassium-rich brine resources in northwe …
  • Galectin Therapeutics Inc (GALT):企業の財務・戦略的SWOT分析
    Summary Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company provides products such as GR-MD-02, GM-CT-01, and others. Its GR-MD-02 is a drug c …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (Actinium), formerly Cactus Ventures Inc, is a biopharmaceutical company. It develops antibody radiation conjugates (ARC), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company's pipeline products include Iomab- …
  • Cotinga Pharmaceuticals Inc (COT):製薬・医療:M&Aディール及び事業提携情報
    Summary Cotinga Pharmaceuticals Inc (Cotinga), formerly Critical Outcome Technologies Inc, is a developer of targeted therapeutics with focus on oncology. The company offers pipeline products such as COTI-2 targeting p53 and COTI-259 targeting KRAS. Its research includes program, indication, screeni …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆